NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/23/2024
Back to search
Official data from USPTO
SYNBIAS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYNBIAS PHARMA
ST13
US500000085804015Class
1, 5, 42
Filing
85804015
Registration
4562242
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
09/23/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
12/17/2012
Registration date
07/08/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/23/2024
Last transaction
09/23/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
8200 Schaffhausen, CH
Examiner
DINALLO, KEVIN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Synbias Pharma AG
Representatives
Thomas W. Brooke HOLLAND & KNIGHT LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; preservatives for pharmaceutical preparations; chemical preparations for pharmaceutical purposesactive chemical ingredients for the manufacture of finished pharmaceuticals for treating various kinds of cancer diseasesdiseases of the immunological systemauto-immune diseasesfor prevention of organ rejection after transplantation
Class 5
Human pharmaceutical preparations for treating various kinds of cancer diseasesdiseases of the immunological systemauto-immune diseasesfor prevention of organ rejection after transplantation
Class 42
Scientific and technological servicesresearchdesignevaluations and engineering appraisals in the fields of chemical intermediatesactive pharmaceutical ingredients and pharmaceutical finished productsprovided by engineers; industrial analysis and research services in the field of chemical intermediatesactive pharmaceutical ingredients and pharmaceutical finished products; engineering; research in the field of chemical research; chemical analysis; chemistry serviceschemistry consultationresearch in the field of chemistryoptimization of chemical processesanalysis for polymorphism determination; research and development of new pharmaceutical preparations for others; biological research; drug and pharmaceutical research services; bacteriological research
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/23/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/23/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/05/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/08/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/16/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/16/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2020
E815
TEAS SECTION 8 & 15 RECEIVED
07/01/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/08/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/22/2014
PUBO
PUBLISHED FOR OPPOSITION
04/22/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/15/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
03/04/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/04/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
03/04/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/04/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/05/2013
GNFR
FINAL REFUSAL E-MAILED
09/05/2013
CNFR
FINAL REFUSAL WRITTEN
09/05/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/13/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2013
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/02/2013
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/02/2013
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
04/02/2013
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
04/02/2013
DOCK
ASSIGNED TO EXAMINER
04/01/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/09/2013
ALIE
ASSIGNED TO LIE
02/05/2013
PAPER RECEIVED
01/31/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2013
NWAP
NEW APPLICATION ENTERED
12/20/2012
Continuous trademark protection
Get notified about every new filing that threatens SYNBIAS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.